Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs
- 1 July 2016
- journal article
- review article
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 12 (4) , 638-654
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trialThe Lancet Neurology, 2013
- Cannabinoids for treatment of chronic non‐cancer pain; a systematic review of randomized trialsBritish Journal of Clinical Pharmacology, 2011
- Smoked cannabis for chronic neuropathic pain: a randomized controlled trialCanadian Medical Association Journal, 2010
- Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy‐induced nausea and vomitingBritish Journal of Clinical Pharmacology, 2010
- Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients with Intractable Cancer-Related PainJournal of Pain and Symptom Management, 2010
- Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind studyBMJ, 2008
- Dose-dependent Effects of Smoked Cannabis on Capsaicin-induced Pain and Hyperalgesia in Healthy VolunteersAnesthesiology, 2007
- Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexiaJournal of Pain and Symptom Management, 1997
- Pulmonary Hazards of Smoking Marijuana as Compared with TobaccoNew England Journal of Medicine, 1988
- Crossover comparison of the antiemetic efficacy of nabilone and alizapride in patients with nonseminomatous testicular cancer receiving cisplatin therapyJournal of Molecular Medicine, 1986